Written questions and answers

Written questions allow Members of Parliament to ask government ministers for information on the work, policy and activities of government departments.

Historical written answers can be found in Hansard.

Find the latest written questions and answers for the 2017-19 session below. We welcome your feedback on this service.

Show
by:
Find by:
Close

UIN

Unique Identifying Number – Every written question in the House of Commons has a UIN per Parliament. In the House of Lords each written questions has a UIN per parliamentary session.
Showing 1-20 out of 10513
Results per page
Results per page 20 | 50 | 100
Expand all answers
Print selected
Q
Asked by Lord Hylton
Asked on: 06 September 2018
Ministry of Justice
Offenders: Housing
Lords
To ask Her Majesty's Government whether all prisons in England and Wales ensure that those leaving on discharge have plans for suitable and affordable accommodation.
A
Answered by: Lord Keen of Elie
Answered on: 20 September 2018

As part of the reforms to probation in 2015 all offenders, including those sentenced to less than 12 months, now get targeted support from probation providers when they leave prison to help them reintegrate into society. This includes working with local partners to help them find accommodation, which is provided by the local authority.

On 27 July, the MOJ announced our intention to end contracts with Community Rehabilitation Companies in 2020.We will be consulting on introducing changes so that probation services do more to help offenders find accommodation and employment on release from custody. We are investing an additional £22m per annum during the current contract period to ensure that CRCs deliver an enhanced ‘Through the Gate’ service to offenders leaving prison. This will also include sustained support to find accommodation and employment on discharge.

As part of the Government’s Rough Sleeping strategy, MoJ and the Ministry of Housing, Communities and Local Government (MHCLG), will be investing approximately £6m over two years in a pilot scheme to help ex-offenders secure suitable accommodation upon release. The Cabinet Office has also introduced a new Reducing Reoffending Board that will work across government to tackle some of the main causes of reoffending, including the lack of suitable accommodation on release

Asked on: 06 September 2018
The Senior Deputy Speaker
House of Lords: Plastics
Lords
To ask the Senior Deputy Speaker what action is being taken by the House of Lords Administration to reduce its use of plastic.
A
Answered by: Lord Laming
Answered on: 20 September 2018

The Senior Deputy Speaker has asked me, as Chairman of the Services Committee, to respond on his behalf.

In April 2018 the Services Committee endorsed a number of measures to reduce the consumption of single-use plastics:

A. Remove water in plastic bottles from sale in catering venues– This will be effective from October 2018, reducing plastic waste immediately.

B. Eliminate the consumption of plastic-lined take-away cups for hot drinks (through substitution) and reduce overall take-away cup waste– This will be effective from October 2018, with plastic-lined disposable cups replaced with a compostable alternative.

In addition, Catering & Retail Services (CRS) will continue to incentivise customers to use china mugs, or their own re-usable cups, when purchasing hot drinks by offering a 10p discount on every purchase. A 25p surcharge on all hot drinks purchased in a disposable take-away cup will be introduced from October 2018 for a twelve-month trial.

C. Substitute the remainder of CRS plastic disposable items– In early 2018 all plastic drinking straws supplied by Catering & Retail Services were replaced with compostable paper straws. Individual condiment sachets have also been replaced with condiment bottles. Remaining plastic catering disposable items used by Catering & Retail Services will be replaced with compostable alternatives from October 2018.

The plastic tumbler cups currently provided in meeting rooms and kitchen facilities will also be replaced with compostable cups.

To capture compostable disposable products (including take-away cups) effectively, 800 compostable waste bins have been purchased and will be deployed across the Estate during the 2018 conference recess.

D. Substitute single-use plastic carrier bags in Retail Services with carrier bags made from paper– The current plastic carrier bag stock is being depleted and alternative bags made from paper (using material from responsibly-managed, FSC-certified forests) have been identified as a replacement.

The following additional measures are being taken:

  • The development of a ‘green’ stationery catalogue, to reduce the consumption of single-use avoidable plastics in stationery purchasing (implementation anticipated for October 2018);
  • The development of a pilot for a re-usable packaging ‘totes’ scheme at the Off-Site Consolidation Centre for all deliveries (implementation anticipated for January 2019); and
  • The development of procedures for incorporating the environmental impact of packaging into the weighting of relevant procurement and tender exercises (implementation anticipated for November 2018).

Asked on: 06 September 2018
Home Office
Counter-terrorism
Lords
To ask Her Majesty's Government whether they will conduct an independent review of how the Prevent programme is currently operating before placing any additional responsibilities on local authorities as recommended by the Joint Committee on Human Rights in its report, Counter-Extremism, published on 20 July 2016 (HL Paper 39), and since; and if not, why not.
Answered on: 20 September 2018

The Government’s work to counter extremism is distinct from, but complementary to, its work to counter terrorism, which includes work that aims to prevent people from becoming terrorists or supporting terrorism.

Prevent is implemented in a proportionate manner that takes into account the level of risk in any given area or institution. The Prevent programme is continually reviewed and updated to reflect the current threat level and it has taken account of other recent reviews, both internal and independent, across the breadth of our counter-terrorism strategy, CONTEST.

As committed to in CONTEST we will increase the transparency of Prevent delivery and open it to public scrutiny. For example, last November, we published data on Prevent and Channel referrals for the first time to increase transparency of the programme, and we published further data on Prevent and Channel this March. We will continue to publish data on an annual
basis.

We do not believe that an independent review of Prevent is necessary.

Q
Asked by Lord Storey
Asked on: 07 September 2018
Department for Education
Secondary Education: Admissions
Lords
To ask Her Majesty's Government what steps they are taking to meet increasing need for places in secondary schools in England.
A
Answered by: Lord Agnew of Oulton
Answered on: 20 September 2018

The government has committed £7 billion between 2015 and 2021 to deliver new school places. This funding is additional to our investment in the free schools programme.

Basic need funding is provided each year to local authorities to help them meet the demand for school places in their local areas. Allocations are based on the local authorities’ own data, meaning they receive funding for all the places they need. Funding is announced several years ahead, to give local authorities time to plan local provision. Allocations through 2021 have been announced, including secondary places. The number of places funded by local authorities can be found in Table 1 of the basic need allocations, which is attached and also available here: https://www.gov.uk/government/publications/basic-need-allocations.

The free schools programme is also continuing to provide secondary places. There are 131 open mainstream secondary free schools that will provide over 117,000 places when at capacity. 71 mainstream secondary free schools have been approved and are due to open in the next few years, providing more than 79,000 places when at capacity. The department is working collaboratively with local authorities to provide free schools to meet basic need.

The latest data shows overall 825,000 additional places were created between May 2010 and May 2017. 248,000 of these were secondary places (including middle schools and all through schools deemed as secondary, and including full final capacity in free schools), with many more delivered since then and in the pipeline. The department is on track to create one million places this decade, the largest increase in school capacity for at least two generations.

Q
Asked by Lord Berkeley
Asked on: 11 September 2018
Department for Transport
High Speed 2 Railway Line
Lords
To ask Her Majesty's Government how many (1) permanent employees, (2) agency staff, (3) consultants, and (4) contractors are employed on the HS2 Phase 1 project.
A
Answered by: Baroness Sugg
Answered on: 20 September 2018

HS2 Ltd currently employ 1,255 permanent employees. 427 individuals directly work in the Phase One Directorate. The remaining workforce includes those working on Phase 2, in addition to employees in enabling teams that support the delivery of the new railway.

There are 4 agency staff also working in the Phase One Directorate. HS2 Ltd does not hold information on the number of consultants and contractors working on Phase 1, as services are contracted through third party companies.

The Department for Transport also employs 28 permanent employees and 1 contractor working in the HS2 Phase One Directorate.

Both HS2 Ltd and the Department for Transport are committed to transparency and publish information about our workforce in the respective Annual Report and Accounts.

All numbers are based on headcount.

Asked on: 11 September 2018
Department for Transport
Convention on Offences and Certain Other Acts Committed on Board Aircraft
Lords
To ask Her Majesty's Government what plans they have to ratify the 2014 Montreal Protocol to help to ensure that they have the appropriate enforcement powers against disruptive air passengers.
A
Answered by: Baroness Sugg
Answered on: 20 September 2018

During this legislative cycle, the Government does not intend to complete the ratification of the International Civil Aviation Organisation (ICAO) Montreal Protocol 2014 on disruptive passengers. The majority of the provisions within this protocol are already part of UK law, and we are confident we can take necessary action in regard to disruptive passengers. For example, the UK already has “state of landing” and “state of operator jurisdiction”, which means that disruptive passengers on any flight that touches down within the UK can be charged and, if necessary, prosecuted. No other European Union countries have ratified the 2014 Montreal Protocol.

Q
Asked by Lord Hylton
Asked on: 11 September 2018
Department of Health and Social Care
Psychiatry
Lords
To ask Her Majesty's Government whether consultant psychiatrists who have assessed or treated patients with mental illnesses remain responsible for those patients when they are moved to other hospitals or discharged; and if so, for how long.
A
Answered by: Lord O'Shaughnessy
Answered on: 20 September 2018

In general, when patients are moved to other hospitals the referring consultant psychiatrist transfers responsibility to the receiving consultant. When a patient is discharged from hospital, they are either followed up by a community mental health service or by their general practitioner (GP) in primary care. When a patient is transferred to a community mental health service, responsibility generally transfers to the consultant in that service.

There are some exceptions, including:

- Patients detained under the Mental Health Act (MHA) 1983 may be given ‘leave of absence’ to another hospital as part of their discharge plan. The transferring consultant, who has ‘Responsible Clinician’ status under the MHA, remains responsible for that patient during the authorised leave period and may recall the patient if necessary; and

- When a patient is followed up under a shared care arrangement between their GP and the secondary care consultant. This is normally managed under a locally agreed protocol.

There are no time limits ascribed to these responsibilities.

Q
Asked by Lord Hylton
Asked on: 11 September 2018
Foreign and Commonwealth Office
Serbia: Kosovo
Lords
To ask Her Majesty's Government whether they support the proposed agreement between the governments of Serbia and Kosovo concerning mutual frontier modifications.
A
Answered on: 20 September 2018

As we have always been clear, normalising relations between Serbia and Kosovo is crucial for the security, stability and prosperity of both countries and the wider region. The Government believes that this should be on the basis of recognition of independent sovereign nations within their current borders. We believe that calls for re-drawing national borders could be de-stabilising. We continue to support the EU-facilitated dialogue with a view to a comprehensive and sustainable solution that benefits both countries.

Q
Asked by Lord Hylton
Asked on: 11 September 2018
Foreign and Commonwealth Office
Turkey: Politics and Government
Lords
To ask Her Majesty's Government what assessment they have made of any influence by the government of Turkey over the expulsion from several countries of individuals allegedly linked to the Gulen Movement; whether they intend to make representations to the government of Turkey about any such influence; and whether membership of the Gulen Movement is currently a ground for expulsion from the UK.
A
Answered on: 20 September 2018

We are aware that the Turkish Government is actively seeking the extradition from third countries of alleged Gulenists. This is a matter between Turkey and the countries involved. We urge all concerned to observe international human rights obligations. The Gulen movement is not proscribed as a terrorist group in the UK so the issue of expulsion does not arise. We will consider extradition requests where there is evidence of criminal wrong-doing by an individual.

Q
Asked on: 11 September 2018
Department of Health and Social Care
Drugs
Lords
To ask Her Majesty's Government what recent discussions they have had with the devolved administrations regarding the supply of medicine to the devolved nations in the event of a no-deal Brexit.
A
Answered by: Lord O'Shaughnessy
Answered on: 20 September 2018

On 23 August 2018 the Department published an open letter online to all pharmaceutical companies asking them to ensure that United Kingdom stockpiles of medicines are appropriate to cope with potential delays at the border that may arise in the event of a no-deal Brexit. A copy of the letter is attached.

At the same time the Department also wrote to pharmaceutical companies that supply the UK with prescription-only-medicines and pharmacy medicines from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019. The Department also asked those suppliers to indicate how they propose to ensure continuity of supply of their products to the National Health Service as part of the Department’s contingency programme. We are unable to provide the names of these companies as this information is commercially sensitive.

General sales list (over-the-counter) medicines were not included in the Department’s request to suppliers to indicate their contingency plans to us, and therefore are not currently formally part of our contingency programme. We have, however, encouraged all medicines suppliers to the UK with a EU/EEA touchpoint to stockpile or make alternative arrangements and are confident that this is the best approach to ensure supply at pharmacies and retail outlets in the event of a no-deal Brexit.

The Department also wrote to hospitals, general practitioners and community pharmacies informing them that they do not need to take any steps to stockpile additional medicines, beyond their business as usual stock levels, as this is not necessary due to our contingency plans in partnership with pharmaceutical companies.

We are not currently aware of any healthcare providers or other health care organisations acquiring medicines in volumes that would qualify as stockpiling but we will work with NHS colleagues to closely monitor and follow up any incidences of over ordering of medicines.

The Department has worked collaboratively with the devolved administrations to ensure a UK-wide approach to our contingency plans which includes the supply of medicines to the devolved nations. Officials from the devolved administrations are members of a cross-Government working group and were informed of our 23 August announcements in advance.

Letter to pharmaceutical companies (PDF Document, 365.22 KB)
Grouped Questions: HL10252 | HL10253 | HL10254 | HL10255
Q
Asked on: 11 September 2018
Department of Health and Social Care
Drugs
Lords
To ask Her Majesty's Government which pharmaceutical companies, if any, they have been working with to ensure that UK stockpiles of medicines are adequate to cope with a no-deal Brexit.
A
Answered by: Lord O'Shaughnessy
Answered on: 20 September 2018

On 23 August 2018 the Department published an open letter online to all pharmaceutical companies asking them to ensure that United Kingdom stockpiles of medicines are appropriate to cope with potential delays at the border that may arise in the event of a no-deal Brexit. A copy of the letter is attached.

At the same time the Department also wrote to pharmaceutical companies that supply the UK with prescription-only-medicines and pharmacy medicines from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019. The Department also asked those suppliers to indicate how they propose to ensure continuity of supply of their products to the National Health Service as part of the Department’s contingency programme. We are unable to provide the names of these companies as this information is commercially sensitive.

General sales list (over-the-counter) medicines were not included in the Department’s request to suppliers to indicate their contingency plans to us, and therefore are not currently formally part of our contingency programme. We have, however, encouraged all medicines suppliers to the UK with a EU/EEA touchpoint to stockpile or make alternative arrangements and are confident that this is the best approach to ensure supply at pharmacies and retail outlets in the event of a no-deal Brexit.

The Department also wrote to hospitals, general practitioners and community pharmacies informing them that they do not need to take any steps to stockpile additional medicines, beyond their business as usual stock levels, as this is not necessary due to our contingency plans in partnership with pharmaceutical companies.

We are not currently aware of any healthcare providers or other health care organisations acquiring medicines in volumes that would qualify as stockpiling but we will work with NHS colleagues to closely monitor and follow up any incidences of over ordering of medicines.

The Department has worked collaboratively with the devolved administrations to ensure a UK-wide approach to our contingency plans which includes the supply of medicines to the devolved nations. Officials from the devolved administrations are members of a cross-Government working group and were informed of our 23 August announcements in advance.

Letter to pharmaceutical companies (PDF Document, 365.22 KB)
Grouped Questions: HL10251 | HL10253 | HL10254 | HL10255
Q
Asked on: 11 September 2018
Department of Health and Social Care
Drugs
Lords
To ask Her Majesty's Government whether any health organisations in the UK, other than pharmaceutical companies, are stockpiling medicines in preparation for a no-deal Brexit.
A
Answered by: Lord O'Shaughnessy
Answered on: 20 September 2018

On 23 August 2018 the Department published an open letter online to all pharmaceutical companies asking them to ensure that United Kingdom stockpiles of medicines are appropriate to cope with potential delays at the border that may arise in the event of a no-deal Brexit. A copy of the letter is attached.

At the same time the Department also wrote to pharmaceutical companies that supply the UK with prescription-only-medicines and pharmacy medicines from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019. The Department also asked those suppliers to indicate how they propose to ensure continuity of supply of their products to the National Health Service as part of the Department’s contingency programme. We are unable to provide the names of these companies as this information is commercially sensitive.

General sales list (over-the-counter) medicines were not included in the Department’s request to suppliers to indicate their contingency plans to us, and therefore are not currently formally part of our contingency programme. We have, however, encouraged all medicines suppliers to the UK with a EU/EEA touchpoint to stockpile or make alternative arrangements and are confident that this is the best approach to ensure supply at pharmacies and retail outlets in the event of a no-deal Brexit.

The Department also wrote to hospitals, general practitioners and community pharmacies informing them that they do not need to take any steps to stockpile additional medicines, beyond their business as usual stock levels, as this is not necessary due to our contingency plans in partnership with pharmaceutical companies.

We are not currently aware of any healthcare providers or other health care organisations acquiring medicines in volumes that would qualify as stockpiling but we will work with NHS colleagues to closely monitor and follow up any incidences of over ordering of medicines.

The Department has worked collaboratively with the devolved administrations to ensure a UK-wide approach to our contingency plans which includes the supply of medicines to the devolved nations. Officials from the devolved administrations are members of a cross-Government working group and were informed of our 23 August announcements in advance.

Letter to pharmaceutical companies (PDF Document, 365.22 KB)
Grouped Questions: HL10251 | HL10252 | HL10254 | HL10255
Q
Asked on: 11 September 2018
Department of Health and Social Care
Drugs
Lords
To ask Her Majesty's Government whether NHS organisations, GPs, community pharmacies and other service providers have been asked to stockpile medicine in the event of a no-deal Brexit; and if not, why not.
A
Answered by: Lord O'Shaughnessy
Answered on: 20 September 2018

On 23 August 2018 the Department published an open letter online to all pharmaceutical companies asking them to ensure that United Kingdom stockpiles of medicines are appropriate to cope with potential delays at the border that may arise in the event of a no-deal Brexit. A copy of the letter is attached.

At the same time the Department also wrote to pharmaceutical companies that supply the UK with prescription-only-medicines and pharmacy medicines from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019. The Department also asked those suppliers to indicate how they propose to ensure continuity of supply of their products to the National Health Service as part of the Department’s contingency programme. We are unable to provide the names of these companies as this information is commercially sensitive.

General sales list (over-the-counter) medicines were not included in the Department’s request to suppliers to indicate their contingency plans to us, and therefore are not currently formally part of our contingency programme. We have, however, encouraged all medicines suppliers to the UK with a EU/EEA touchpoint to stockpile or make alternative arrangements and are confident that this is the best approach to ensure supply at pharmacies and retail outlets in the event of a no-deal Brexit.

The Department also wrote to hospitals, general practitioners and community pharmacies informing them that they do not need to take any steps to stockpile additional medicines, beyond their business as usual stock levels, as this is not necessary due to our contingency plans in partnership with pharmaceutical companies.

We are not currently aware of any healthcare providers or other health care organisations acquiring medicines in volumes that would qualify as stockpiling but we will work with NHS colleagues to closely monitor and follow up any incidences of over ordering of medicines.

The Department has worked collaboratively with the devolved administrations to ensure a UK-wide approach to our contingency plans which includes the supply of medicines to the devolved nations. Officials from the devolved administrations are members of a cross-Government working group and were informed of our 23 August announcements in advance.

Letter to pharmaceutical companies (PDF Document, 365.22 KB)
Grouped Questions: HL10251 | HL10252 | HL10253 | HL10255
Q
Asked on: 11 September 2018
Department of Health and Social Care
Drugs
Lords
To ask Her Majesty's Government what steps they are taking to ensure that over-the-counter medicines will be available from local pharmacies and other retail outlets in the UK in the event of a no-deal Brexit.
A
Answered by: Lord O'Shaughnessy
Answered on: 20 September 2018

On 23 August 2018 the Department published an open letter online to all pharmaceutical companies asking them to ensure that United Kingdom stockpiles of medicines are appropriate to cope with potential delays at the border that may arise in the event of a no-deal Brexit. A copy of the letter is attached.

At the same time the Department also wrote to pharmaceutical companies that supply the UK with prescription-only-medicines and pharmacy medicines from, or via, the European Union/European Economic Area (EEA), asking them to ensure they have a minimum of six weeks’ additional supply in the UK, over and above their business as usual operational buffer stocks, by 29 March 2019. The Department also asked those suppliers to indicate how they propose to ensure continuity of supply of their products to the National Health Service as part of the Department’s contingency programme. We are unable to provide the names of these companies as this information is commercially sensitive.

General sales list (over-the-counter) medicines were not included in the Department’s request to suppliers to indicate their contingency plans to us, and therefore are not currently formally part of our contingency programme. We have, however, encouraged all medicines suppliers to the UK with a EU/EEA touchpoint to stockpile or make alternative arrangements and are confident that this is the best approach to ensure supply at pharmacies and retail outlets in the event of a no-deal Brexit.

The Department also wrote to hospitals, general practitioners and community pharmacies informing them that they do not need to take any steps to stockpile additional medicines, beyond their business as usual stock levels, as this is not necessary due to our contingency plans in partnership with pharmaceutical companies.

We are not currently aware of any healthcare providers or other health care organisations acquiring medicines in volumes that would qualify as stockpiling but we will work with NHS colleagues to closely monitor and follow up any incidences of over ordering of medicines.

The Department has worked collaboratively with the devolved administrations to ensure a UK-wide approach to our contingency plans which includes the supply of medicines to the devolved nations. Officials from the devolved administrations are members of a cross-Government working group and were informed of our 23 August announcements in advance.

Letter to pharmaceutical companies (PDF Document, 365.22 KB)
Grouped Questions: HL10251 | HL10252 | HL10253 | HL10254
Asked on: 11 September 2018
Ministry of Housing, Communities and Local Government
Councillors: Wales
Lords
To ask Her Majesty's Government what was the total number of elected local councillors, at all levels of local government, in Wales in (1) 1988, (2) 1998, (3) 2008, and (4) 2018.
Answered on: 20 September 2018

This information is not held centrally.

Q
Asked by Lord Bradshaw
Asked on: 12 September 2018
Department for Transport
Buses: Exhaust Emissions
Lords
To ask Her Majesty's Government whether, and to what extent, bus emissions of pollutants have reduced in the last five years; and what reduction in bus emissions they anticipate in the next five years.
A
Answered by: Baroness Sugg
Answered on: 20 September 2018

Figures for buses alone are unavailable. Figures for actual and projected combined bus and coach pollutant emissions are shown in the table, where available.

Year

CO

NOx

PM10

PM2.5

Benzene

1,3-butadine

Lead

SO2

2011

6.52

30.76

0.39

0.39

0.00

0.02

0.00

0.02

2012

6.32

27.69

0.35

0.35

0.00

0.02

0.00

0.02

2013

6.37

26.23

0.32

0.32

0.00

0.02

0.00

0.02

2014

5.89

23.38

0.28

0.28

0.00

0.01

0.00

0.02

2015

5.08

19.44

0.23

0.23

0.00

0.01

0.00

0.02

2016

4.26

14.95

0.18

0.18

0.00

0.01

0.00

0.02

2020

n/a

8.27

n/a

0.10

n/a

n/a

n/a

0.02

Source: Ricardo – AEA/DEFRA (NAEI)

Units: Thousand tonnes

n/a: projections not available

Q
Asked by Lord Lucas
Asked on: 12 September 2018
Department of Health and Social Care
Gender Recognition: Young People
Lords
To ask Her Majesty's Government what assessment they have made of whether the NHS document A guide for young trans people in the UK stereotypes gender characteristics and advises young people to go abroad for puberty blocking treatment which is not permitted in the UK.
A
Answered by: Lord O'Shaughnessy
Answered on: 20 September 2018

No assessment has been made of the content of the document A guide for young trans people in the UK as it is no longer current.

This document was published in 2007, before NHS England’s inception in 2013, when it became the direct commissioner of specialised gender dysphoria services for the population of England.

In 2016, NHS England published a clinical commissioning policy that sets out strict guidelines regarding the prescription of puberty-blocking and cross-sex hormones in youngsters. These drugs may only be prescribed with the agreement of a specialist multidisciplinary team and after a diagnosis of gender dysphoria has been made following a careful assessment of the individual, and generally once the patient is around 15 years old for hormone blockers and 16 years old for cross sex hormones.

A copy of NHS England’s commissioning policy NHS Standard Contract for Gender Identity Development Service For Children And Adolescents is attached.

NHS England commissioning policy (PDF Document, 1.08 MB)
Q
Asked on: 12 September 2018
Department for Transport
East Coast Railway Line: Trains
Lords
To ask Her Majesty's Government which organisation made the decision to order the new Azuma trains; what is the extent of any technical problems with the Azuma trains; what plans are in place to deal with those problems; and when they anticipate the new trains will be fully operational as part of the regular timetable.
A
Answered by: Baroness Sugg
Answered on: 20 September 2018

The Intercity Express Programme (IEP) to deliver the new Great Western and East Coast Mainline Intercity Express Trains (IETs) is a government-led investment which was initiated by the Department for Transport when the Invitation to Tender was published in 2007. It is not uncommon when introducing new trains on an existing network for there to be some teething problems. This is why time is set aside to identify any issues as far as possible before the launch of passenger service and Hitachi and Network Rail are working together to resolve these issues with the aim of getting these trains ready for passenger service. The introduction of the new trains will deliver more seats and faster journeys for decades to come. The full benefits of these IETs will be delivered once the full fleet is in service alongside introduction alongside introduction of a new timetable.

Q
Asked on: 12 September 2018
Department for Transport
Roads: Accidents
Lords
To ask Her Majesty's Government whether they have received the road casualty data for London for 2017; and if not, when they expect to receive that data.
A
Answered by: Baroness Sugg
Answered on: 20 September 2018

The Department for Transport announced on Thursday 17 May 2018 that the publication of Reported road casualties Great Britain, main results: 2017, which had been scheduled for end June 2018, would be delayed until September. This was due to the non-availability of complete 2017 road casualty data for London, as a result of technical and data quality issues following the implementation of the Case Overview and Preparation Application (COPA) reporting system by the Metropolitan Police Service in November 2016.

The full statement is available on the Road accidents and safety statistics collections page on gov.uk. The Department announced a revised publication date of Thursday 27 September 2018 in the release calendar for Official Statistics. Officials have received the road casualty data for London as planned to meet this revised publication date.

Grouped Questions: HL10315
Q
Asked on: 12 September 2018
Department for Transport
Roads: Accidents
Lords
To ask Her Majesty's Government whether, and if so why, there is a delay in receiving full and timely data on road casualties in London, following talks between the Department for Transport, the Metropolitan Police and Transport for London.
A
Answered by: Baroness Sugg
Answered on: 20 September 2018

The Department for Transport announced on Thursday 17 May 2018 that the publication of Reported road casualties Great Britain, main results: 2017, which had been scheduled for end June 2018, would be delayed until September. This was due to the non-availability of complete 2017 road casualty data for London, as a result of technical and data quality issues following the implementation of the Case Overview and Preparation Application (COPA) reporting system by the Metropolitan Police Service in November 2016.

The full statement is available on the Road accidents and safety statistics collections page on gov.uk. The Department announced a revised publication date of Thursday 27 September 2018 in the release calendar for Official Statistics. Officials have received the road casualty data for London as planned to meet this revised publication date.

Grouped Questions: HL10314
Expand all answers
Print selected
Showing 1-20 out of 10513
Results per page
Results per page 20 | 50 | 100